Morning Dow Report: Will Earnings Rescue the Market?

The Dow moved higher this morning as earnings season began in earnest with an announcement from JPMorgan Chase. Find out why Intel rose even as Merck gave up some of its gains from yesterday.

Jan 14, 2014 at 11:00AM

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis.

The Dow celebrated the beginning of its first earnings season in 2014, with stocks climbing on hopes that the extensive negative guidance that dozens of companies have provided in advance of their official earnings releases will give way to more positive results from the bulk of the market. As of 11 a.m. EST, the Dow Jones Industrials (DJINDICES:^DJI) were up 64 points, with Intel (NASDAQ:INTC) leading the way higher for the average. JPMorgan Chase's (NYSE:JPM) earnings results also helped the Dow somewhat, even as Merck (NYSE:MRK) gave up some of its gains from yesterday.

For Intel, which was up more than 3.5%, positive recommendations from JPMorgan and Jefferies pointed to the potential for the chip maker's stock to rise considerably from here. Even though Intel has been slow to get its processors into mobile devices, the company has a considerable pricing advantage as a result of its in-house production capabilities. Indeed, Intel has even identified a possible growth opportunity by making its foundries available to outside vendors, which could open up new ways to boost profits and help the company become even more relevant in the tech sector going forward.

JPMorgan Chase rose less than half a percent despite beating analyst estimates on earnings by $0.06 per share. The bank reported a 7% drop in profit during the fourth quarter, with mortgage originations continuing to decline sharply and poor investment results weighing on overall revenue. Higher marketing expenses also raised some concerns, although profits from consumer and community banking were up due largely from a reduction in loan-loss provisions. As interest rates rise, it'll be increasingly important for JPMorgan to see success in areas like credit card sales volume and consumer lending in order to pick up the slack in more rate-sensitive areas. Moreover, it's unclear whether JPMorgan earnings by themselves will be enough to convince investors that the Dow won't suffer a correction.

Merck fell 1.5% after announcing a voluntary recall of its Liptruzet cholesterol drug, citing packaging defects for the action. Merck said defective foil pouches could allow air and moisture to decrease the effectiveness of the drug, and the company expects to be out of stock of the drug in the U.S. until it can manufacture replacements. In addition, an infant-diarrhea vaccine that Merck makes was found in studies to have slight risks of bowel blockage. The findings won't change the recommendations of health authorities, according to the Centers for Disease Control and Prevention, but they do note how important it is for Merck and other companies to stay abreast of the safety considerations of their products.

Count on earnings, but focus on the long run
Earnings might well end up pulling the market higher, especially for companies that have set the bar relatively low for success. Yet in the long run, investors need to realize the long-term potential that stocks have to provide strong returns. In our brand-new special report, "Your Essential Guide to Start Investing Today," The Motley Fool's personal finance experts show you why investing is so important and what you need to do to get started. Click here to get your copy today -- it's absolutely free.

Fool contributor Dan Caplinger owns warrants on JPMorgan Chase. The Motley Fool recommends Intel. The Motley Fool owns shares of Intel and JPMorgan Chase. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers